**Core Concept**
The question is testing the knowledge of reversal agents used in anesthesia, specifically for the reversal of non-depolarizing neuromuscular blockers like d-Tubocurarine (d-TC). The underlying concept involves the use of cholinesterase inhibitors to increase acetylcholine levels at the neuromuscular junction, thereby overcoming the blockade caused by the non-depolarizing agent.

**Why the Correct Answer is Right**
Neostigmine is a cholinesterase inhibitor that works by inhibiting the enzyme acetylcholinesterase, which breaks down acetylcholine. By preventing the breakdown of acetylcholine, neostigmine increases the concentration of acetylcholine available to bind to nicotinic receptors at the neuromuscular junction, reversing the blockade caused by d-TC. This is achieved through the inhibition of acetylcholinesterase, allowing acetylcholine to accumulate and facilitate muscle contraction.

**Why Each Wrong Option is Incorrect**
**Option A:** Atropine is an anticholinergic agent that blocks muscarinic receptors, leading to decreased acetylcholine levels at the neuromuscular junction. It is used to counteract the muscarinic effects of neostigmine, such as bradycardia and excessive salivation, but it does not reverse the blockade caused by non-depolarizing agents.

**Option B:** Atracurium is a non-depolarizing neuromuscular blocker, similar to d-TC. It works by competitively blocking nicotinic receptors at the neuromuscular junction, leading to muscle paralysis. It is not a reversal agent and would worsen the blockade if used in this context.

**Option C:** Diazepam is a benzodiazepine that acts on the central nervous system to produce sedation, anxiolysis, and muscle relaxation. It does not have a direct effect on the neuromuscular junction and would not be effective in reversing the blockade caused by d-TC.

**Clinical Pearl / High-Yield Fact**
When reversing non-depolarizing neuromuscular blockers, it is essential to ensure that the patient has adequate respiratory function and that the reversal agent is administered in a controlled environment to avoid rapid changes in neuromuscular function.

**Correct Answer:**
✓ Correct Answer: D. Neostigmine